Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Androgens can both increase and decrease hair growth in different parts of the body.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Oral minoxidil is a safe and effective treatment for patterned hair loss.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Finasteride effectively treats hair loss in transgender men with few side effects.

Finasteride improves hair loss in women with hyperandrogenism.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Finasteride reduces hair growth better, but spironolactone has more side effects.